Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Lung Cancer
Interventions: DRUG: Dichloroacetate (DCA)
Sponsor: Jonsson Comprehensive Cancer Center